Life Sciences
Life Sciences
Michael K. Green
CPA
Partner
Darren R. Jones
CIA
Principal
Mark Scallon
Principal
David A. Gregory
Principal
Mike D. McKee
CPA
Managing Partner
Minako Steel
CPA
Director
John Finan
MBA
Director
Jeff K. Clayton
Principal
Doron Bass
Partner
Jeremy Chapman
CPA
Partner
David W. Cortney
CPA, MBA
Partner Emeritus
Brad DeNoyer
Managing Partner
Brian P. Francese
CPA
Partner
Jacque J. Lee
CPA, MBT
Partner
Peter S. Noce
CPA
Partner
Keith Troutman
CPA, MBA
Partner
Jeff Krull
CPA, CISA
Partner
Baker Tilly helps life sciences companies address the unique needs and opportunities at all stages of the business and product life cycle. From assurance and tax to advisory and support solutions, our integrated team of industry specialists collaborate to provide practical, actionable recommendations and analyses that can be easily operationalized.
By the numbers
450
Serving nearly 450 pharmaceutical, biotech and medical device companies
15
Top 15 healthcare consulting management firm (Modern Healthcare)
500
Our team of more than 500 professionals includes masters-trained policy specialists, former medical directors, physicians, CFOs, health economists, epidemiologists and pharma executives
Our solutions
Baker Tilly has structured our solutions in a way that marshals in the right resources to address the unique challenges our client's face while operating a life sciences company. Our team, comprised of more than 500 individuals, supports our clients through assurance, specialty tax, and advisory and support services, so that we can protect the value of your business while also seizing new opportunities for tomorrow’s success.
Life sciences companies operate in a highly regulated environment and must rely on a large volume of information to make daily decisions. Whether your life sciences company needs its financial statements prepared, compiled, reviewed, or audited; understanding new or upcoming accounting standards; or something more outside of the box, our team of specialized assurance professionals are here to help address your company’s unique needs and reach your goals.
Life sciences companies face a variety of complicated tax considerations that can have large financial impacts on their business. At Baker Tilly, our specialty tax services team can assist you and your organization in maximizing tax deductions, understanding tax reform implications, utilizing tax credits, reducing your tax liability, mitigating risks and more.
From market access planning to establishing a commercial function to creating an effective healthcare compliance program, many life sciences companies rely on external support provided by advisory services firms to assist in a variety of activities. Baker Tilly’s advisory and support services provide client’s guidance and/or outsourced resources to assist in addressing the complex issues that arise during business operations.
Life sciences industry forecast for 2023 and beyond
Join us for our second annual Life Sciences Industry Forecast event where we will explore developments from this past year, discuss the current state of the environment and look at trends and challenges shaping the industry in 2023 and beyond.
“The Baker Tilly team understands the financial issues related to growth and development of biotech companies and helps ensure we address those issues appropriately. Baker Tilly’s international reach is also impressive. With nearly half of our manufacturing taking place overseas, we need quality support across the globe. The Baker Tilly International network has provided us with seamless and sound business and reporting advice. We receive the same quality and level of service regardless of location.”- Chief Financial Officer
Featured insights
Medical affairs and the value of epidemiology expertise
Download Baker Tilly’s and the Accreditation Council for Medical Affairs’ (ACMA) informative whitepaper to learn about the changing role of the medical affairs function within life sciences companies and the value of epidemiological expertise.
Ransomware prevention guide
Our ransomware prevention guide explores eight leading cybersecurity practices to minimize an organization’s chance of a ransomware attack.
Market access checklist
Baker Tilly’s market access checklist is designed to help you and your organization secure reimbursements and achieve optimal market access for your medical device, drug or diagnostic.
Life sciences industry outlook for 2022 and beyond
Download our informative whitepaper to help your life sciences company spot important developments that should be considered for 2022 and beyond
At a glance
The coronavirus pandemic has had a profound and lasting impact throughout all aspects of the life sciences industry, including activities related to research and development (R&D), customer demand forecasting and generation, supply chain, government contracting and more. Whether your company is public or privately held and whether you are operating in a single country or are a multinational entity, all pharmaceutical, biotech and medical device companies are experiencing high levels of disruption in business activities. From conducting virtual interactions or preparedness activities for a financing or merger and acquisition (M&A) transaction, government funding audits or developing local or international tax strategies, our team has the experience to minimize the fear, uncertainty and doubt of navigating today’s ever-changing environment.
At Baker Tilly, our team of professionals works with private and publicly traded life sciences companies, private equity firms and portfolio companies to help meet company goals in all stages of the business lifecycle – from pre-commercial to growth to maturity to exit. Our work with stakeholders across the healthcare ecosystem – including life sciences, health plans and healthcare provider companies –provides us with a 360-degree industry view to address your needs.
In addition, Baker Tilly’s established, in-house led departments address a wide range of functional areas within life sciences companies. Through our comprehensive industry knowledge, deep experience and strategic relationships from our work with hundreds of life sciences companies worldwide, we are able to provide actionable ideas and solutions to help companies grow their business now, while anticipating tomorrow. Our team members have run global life sciences companies and have been published in numerous peer-reviewed publications and medical journals, frequently present at global MBA and university programs as guest lecturers, and speak internationally at widely regarded conferences in their respective experience areas.
Solutions for life sciences companies
Assurance
Baker Tilly pairs deep industry knowledge with service specialization to deliver high quality accounting and assurance services.
Tax
Contributing to clients’ success by accelerating tax deductions, increasing tax credits, reducing cash taxes and mitigating risks
Life Sciences Advisory & Support Services
Comprehensive advisory strategies to protect and enhance your value in today's dynamic risk environment.
Market Access Strategy & Support
Commercial growth success from market access planning to post-launch growth
Compliance & Ethics for Life Science Companies
Baker Tilly's life sciences practices provides comprehensive solutions to solve your organization's most pressing global compliance and ethics needs.
Commercial Enablement
Baker Tilly’s commercial enablement team offers a suite of solutions that can help your life science company navigate through the entirety of the commercial enablement process for new and existing products.
Government and Commercial Pricing & Contracting
Helping life sciences clients establish and manage performance of their government and commercial contracts to build market strength and maintain compliance.
Medical Affairs Platform & Strategy
Our medical affairs solutions assist with developing and executing scientific and evidence generation and communication plans throughout the product life cycle.
Supply Chain Resilience
We can help your supply chain become more flexible and responsive to deal with unplanned disruptions.
Enterprise Risk Management for Life Science Companies
Supporting life sciences companies in establishing consistent risk governance mechanisms to identify, manage and mitigate risks throughout the enterprise and through the product life cycle, from research through commercialization.
Drug Price Transparency & Reporting
Price transparency program design and support.
Internal Audit for Life Science Companies
Helping address the unique risks to life sciences companies, including commercial, medical, safety, quality, regulatory, and government pricing and contracting activities.
Third-Party Risk Management & Due Diligence
Helping life sciences companies evaluate third party relationships to ensure compliance with global anti-bribery and corruption laws
Data Privacy & Protection for Life Sciences Companies
Satisfy regulatory obligations through customized privacy support which protects the personal information of employees and clients.
Compliance Risk & Needs Assessment
Baker Tilly Life Sciences helps clients identify areas of risk across the organization and recommends strategic paths forward for protecting value and mitigating risk
Compliance Auditing & Monitoring
Baker Tilly life sciences helps its clients address identified areas of risk across the organization through the design and execution of robust auditing and monitoring programs
Global Spend Transparency Reporting Services
Helping life sciences companies navigate the expanding spend transparency environment to ensure complete, accurate and timely compliance with spend reporting obligations for transfers of value to HCPs and HCOs.
Fair Market Value & KOL Tiering
Helping life sciences companies develop fair market value (FMV) for consulting engagements with healthcare professionals (HCPs) as well as non-HCPs.
fmvNOW™
Direct access to FMV hourly rates across different KOL tiers and countries, and throughout current and past years.
rwdNOW™ for Pinpoint Targeting & Market Access Activation
Baker Tilly’s rwdNOW is a customizable market assessment tool based on real-world data.
Philanthropy & External Funding Program Design & Support
The Baker Tilly life sciences team supports clients in developing strategies to manage funding types, while also employing a strategy to enhance the value of our client’s corporate identity in the global healthcare economy.
Patient Support & Advocacy
Patient support programs have become a standard business practice to ensure patient access, however, life sciences, medical device and pharmaceutical companies must be cautious as regulatory scrutiny increases.
Transactions
Baker Tilly works with clients on mergers, acquisitions, capital sourcing and markets, project finance, due diligence, valuation and transactions
Research & Development Credits
Baker Tilly's research and development credit professionals can help you find R&D activities in areas you may not have thought qualify.HITRUST CSF Assessment Services
The HITRUST CSF provides an integrated, certifiable approach to securing PHI. Any organization handling PHI on behalf of customers may be required to obtain a HITRUST CSF certification.